Overview and Scope
Metabolomics is a branch of bio-analytics that deals with the quantification and identification of metabolic small molecules found in cells, tissues, organs, and biological fluids. Research in the area of metabolomics focuses on the chemical reactions that metabolites go through.
Sizing and Forecast
The metabolomics market size has grown rapidly in recent years. It will grow from <b>$3.11 billion in 2023 to $3.6 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. </b> The growth in the historic period can be attributed to advancements in healthcare, drug discovery and development, disease biomarker identification, academic and research institutions, nutrition and food science.
The metabolomics market size is expected to see rapid growth in the next few years. It will grow to <b>$6.68 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. </b> The growth in the forecast period can be attributed to personalized healthcare, drug safety and efficacy, microbiome and gut health, environmental and agricultural applications, regenerative medicine. Major trends in the forecast period include integration with other omics, targeted metabolomics, single-cell metabolomics, data analytics and ai, point-of-care testing.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Segmentation & Regional Insights
The metabolomics market covered in this report is segmented –
1) By Product & Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments: Separation Techniques, Detection Techniques, Bioinformatics Tools and Database, Bioinformatics Services
<b>North America</b> was the largest region in the metabolomics market in 2023. <b>Western Europe</b> was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp
Major Driver Impacting Market Growth
The increasing prevalence rate of cancer drives the metabolomics market growth. Metabolomics screens the potential biomarkers (specific cells, molecules, or genes, gene products, enzymes, or hormones) to measure the cancer drug responsiveness aiding early diagnosis. For instance, according to a report by WebMD, an American publisher of health-related news, in 2021, 10 million people died of cancer worldwide. For instance, in January 2022, according to the American Cancer Society, a US-based non-profit health organization dedicated to cancer elimination, the United States is anticipated to have 1.9 million new instances of cancer and 609,360 deaths due to cancer in 2022, for a total of 1,670 fatalities each day. Metabolomics approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp., and others have adopted metabolomics as a tool for early detection and cure for cancer.
Key Industry Players
Major companies operating in the metabolomics market include <b>Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, Kore Technologies Ltd., Dani Instruments SpA, Perkinelmer Inc., Evans Analytical Group LLC, LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Southern Research Company Inc., Alcami Corporation, Charles River Laboratories International Inc., Eremid Genomic Services LLC, Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.</b>
The metabolomics market report table of contents includes:
1. Executive Summary
2.Metabolomics Market Characteristics
3.Metabolomics Market Trends And Strategies
4. Metabolomics Market analysis
5. Metabolomics Market Size And Growth
6.Metabolomics Segmentation
7. Metabolomics Regional And Country Analysis
.
.
.
27.Metabolomics Competitive Landscape And Company Profiles
28.Metabolomics Key Mergers And Acquisitions
29.Metabolomics Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Human Metabolome Technologies Inc.
- Metabolon Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
